AMPAKINE Trademark

Trademark Overview

On Friday, September 24, 1993, a trademark application was filed for AMPAKINE with the United States Patent and Trademark Office. The USPTO has given the AMPAKINE trademark a serial number of 74439919. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, November 16, 2018. This trademark is owned by Cortex Pharmaceuticals, Inc.. The AMPAKINE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical compositions for treatment of deficits in or improvement of memory or cognition
ampakine

General Information

Serial Number74439919
Word MarkAMPAKINE
Filing DateFriday, September 24, 1993
Status800 - REGISTERED AND RENEWED
Status DateFriday, November 16, 2018
Registration Number2157044
Registration DateTuesday, May 12, 1998
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 8, 1994

Trademark Statements

Certificate of Correction for RegistrationIn the Statement, Column 1, line 1, "CALIFORNIA" should be deleted, and, "DELAWARE", should be inserted, and, In the Statement, Column 1, line 4, "92718", should be deleted, and, "92618" should be inserted.
Goods and Servicespharmaceutical compositions for treatment of deficits in or improvement of memory or cognition

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 1993
Primary Code005
First Use Anywhere DateTuesday, March 29, 1994
First Use In Commerce DateWednesday, December 18, 1996

Trademark Owner History

Party NameRESPIRERX PHARMACEUTICALS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressGLEN ROCK, NJ 07452
Party NameCortex Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameCortex Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameCortex Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Friday, November 16, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, November 16, 2018REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, November 16, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, November 16, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 9, 2018TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 9, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 2, 2010CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, March 29, 2010TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, March 29, 2010POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, March 23, 2010TEAS SECTION 7 REQUEST RECEIVED
Monday, March 31, 2008REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, March 31, 2008REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, March 27, 2008ASSIGNED TO PARALEGAL
Friday, March 21, 2008TEAS SECTION 8 & 9 RECEIVED
Friday, August 17, 2007CASE FILE IN TICRS
Sunday, January 25, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 19, 2003REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, May 12, 1998REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 1998ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 10, 1998ASSIGNED TO EXAMINER
Friday, March 6, 1998STATEMENT OF USE PROCESSING COMPLETE
Saturday, November 30, 1996USE AMENDMENT FILED
Monday, January 5, 1998PETITION TO DIRECTOR - GRANTED
Tuesday, June 17, 1997PETITION TO DIRECTOR RECEIVED
Tuesday, June 17, 1997PETITION TO DIRECTOR RECEIVED
Monday, May 19, 1997ABANDONMENT - NO USE STATEMENT FILED
Monday, May 19, 1997EXTENSION 5 DENIAL LETTER MAILED
Monday, May 19, 1997EXTENSION 5 DENIAL LETTER PREPARED
Friday, November 15, 1996EXTENSION 5 FILED
Friday, June 21, 1996EXTENSION 4 GRANTED
Thursday, March 28, 1996EXTENSION 4 FILED
Saturday, December 23, 1995EXTENSION 3 GRANTED
Monday, November 27, 1995EXTENSION 3 FILED
Monday, July 10, 1995EXTENSION 2 GRANTED
Tuesday, May 30, 1995EXTENSION 2 FILED
Tuesday, January 24, 1995EXTENSION 1 GRANTED
Tuesday, November 29, 1994EXTENSION 1 FILED
Tuesday, May 31, 1994NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 1994PUBLISHED FOR OPPOSITION
Friday, February 4, 1994NOTICE OF PUBLICATION
Monday, January 10, 1994APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 8, 1994ASSIGNED TO EXAMINER

Related Keywords

ampakine memory cognition improvement deficits compositions treatment pharmaceutical